59 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 59 of 59 clinical reviews.
Tadalafil (Cialis) is not FDA-approved for erectile dysfunction or BPH in adolescents aged 12 to 17. This evidence-based review covers off-label risk, pediatric pharmacology data from PAH trials, growth considerations, and mental-health monitoring.
A clinical guide to monitoring tadalafil use in adolescents aged 12 to 17, covering off-label indications, growth, cardiovascular, and mental-health surveillance, with dosing tables, safety signals, and guideline-anchored recommendations.
Evidence-based tadalafil dosing guide for adults aged 30 to 49, covering on-demand and daily regimens for erectile dysfunction and BPH, with trial data, dose adjustments, and clinical considerations.
Tadalafil (Cialis) is taken by mouth, not by injection. Learn how tadalafil works as an oral PDE5 inhibitor, when penile self-injection therapy applies instead, and how these two ED treatment pathways compare.
An evidence-based breakdown of every clinically significant drug-drug interaction for tadalafil (Cialis), including nitrates, alpha-blockers, CYP3A4 inhibitors, antihypertensives, and more. Includes mechanisms, clinical thresholds, and management guidance.
How much does Cialis cost in Hawaii in 2026? Brand runs ~$450/month list price, but cash-pay generics average $80/month and compounded tadalafil starts at $40/month. Full breakdown inside.
How much does Cialis cost in West Virginia in 2026? Cash prices, generic tadalafil, compounded options, Medicaid coverage, and insurance tips for WV residents.
Evidence-based tadalafil dosing guide for adults aged 50 to 64, covering on-demand vs. daily protocols, dose adjustments for comorbidities and polypharmacy, and cardiovascular safety data.
A guide to tadalafil dosing in patients 65 and older, covering starting doses, renal and hepatic adjustments, drug interactions, falls risk, and when to reconsider treatment.
A guide to tadalafil dosing for men aged 18-29, covering on-demand vs. Daily regimens, fertility considerations, safety data, and how to talk to your prescriber.
A clinical guide to tadalafil dosing in adolescents aged 12-17, covering FDA-approved indications, off-label use, safety data, monitoring requirements, and prescribing considerations for pediatric and adolescent patients.
A guide to tadalafil food and supplement interactions, including grapefruit, alcohol, nitrates, and common supplements that alter PDE5 inhibitor pharmacokinetics.
A clinician-level review of tadalafil's pipeline: new delivery systems, combination therapies, emerging indications, and the trials reshaping how this PDE5 inhibitor will be used beyond erectile dysfunction and BPH.
Evidence-based monitoring guide for tadalafil (Cialis) use in adults 65 and older, covering renal function, blood pressure, drug interactions, falls risk, and deprescribing timelines.
A guide to tadalafil dosing, safety, and drug interactions in transplant recipients, people living with HIV, older adults, and other special populations. Includes trial data, FDA label guidance, and clinical decision frameworks.
A clinical overview of tadalafil manufacturing origins, generic entry, FDA shortage events, and current supply chain status for Cialis and its generic equivalents.
Evidence-based guide to managing a missed dose of daily tadalafil (Cialis). Covers pharmacokinetics, clinical timing windows, and when to skip vs. double up.
A complete clinical guide to monitoring tadalafil use in adults aged 30 to 49, covering cardiovascular screening, blood pressure checks, liver and renal function, drug interactions, and when to adjust dosing.
Evidence-based monitoring guide for tadalafil (Cialis) in adults aged 50 to 64, covering cardiovascular screening, renal and hepatic labs, blood pressure targets, drug interactions, and when to adjust dosing.
Evidence-based monitoring guide for young adults aged 18-29 taking tadalafil (Cialis) for erectile dysfunction, covering labs, cardiovascular checks, fertility considerations, and follow-up intervals.
A guide to tadalafil safety in children under 12, covering FDA labeling, approved pediatric indications, dosing data from clinical trials, and monitoring requirements.
A deep dive into tadalafil safety during pregnancy and breastfeeding, covering FDA classification, animal data, placental transfer, PDE5 physiology in pregnancy, and clinical decision-making for women who take Cialis for PAH or other indications.
A clinician-grade review of tadalafil real-world evidence from registries, claims databases, and observational cohorts covering erectile dysfunction, BPH, cardiovascular safety, and adherence patterns.
A physician-level review of tadalafil's regulatory approvals, patent expirations, generic availability, and prescribing classifications across the US, EU, Canada, and the UK.
Evidence-based safety profile of tadalafil (Cialis) in adults aged 30 to 49, covering side effects, cardiovascular risk, drug interactions, daily vs. on-demand dosing, and clinical monitoring.
Evidence-based safety guide for tadalafil (Cialis) in adults aged 50 to 64, covering cardiovascular risk, drug interactions, dosing adjustments, and monitoring recommendations.
A guide to tadalafil safety in men aged 18 to 29, covering cardiovascular risks, fertility effects, drug interactions, daily vs. On-demand dosing, and when to see a doctor.
Evidence-based review of tadalafil safety in geriatric patients, covering dose adjustments, drug interactions, fall risk, renal considerations, and deprescribing strategies for men over 65.
A clinical history of tadalafil from early PDE5 research through FDA approval, mechanism of action, key trials, and the evolution of daily dosing for ED and BPH.
Current Cialis (tadalafil) prices in Alaska for 2026, including cash-pay costs, Medicaid coverage, compounded tadalafil options, telehealth access, and discount programs.
Current Cialis (tadalafil) prices in Louisiana for 2026, including cash-pay costs, Medicaid coverage, compounded tadalafil options, insurance details, and discount programs.
What Cialis and generic tadalafil cost in Washington in 2026, including cash prices, Medicaid coverage, insurance options, compounded tadalafil, and discount programs.
How to adjust tadalafil (Cialis) doses in patients with mild or moderate hepatic impairment, including FDA label limits, pharmacokinetic data, and clinical guidance for prescribers.
Evidence-based guide to tadalafil (Cialis) dosing adjustments in chronic kidney disease and dialysis, including mechanism of action, pharmacokinetics, and safety data with PubMed-cited references.
A physician-level breakdown of how tadalafil (Cialis) works, from nitric oxide release to PDE5 inhibition, smooth muscle relaxation, and the pharmacokinetic properties that set it apart from sildenafil and vardenafil.
Evidence-based monitoring schedule for Cialis (tadalafil) including baseline labs, follow-up exams, and ongoing safety checks for erectile dysfunction and BPH patients.
A clinician-grade review of tadalafil (Cialis) off-label applications, from Raynaud phenomenon to ureteral stone expulsion, graded by trial quality and guideline support.
A guide to tadalafil (Cialis) overdose management, including symptoms, treatment protocols, pharmacokinetics at supratherapeutic doses, and when to seek emergency care.
A complete timeline of Cialis (tadalafil) patents, Paragraph IV challenges, FDA generic approvals, and what the shift to generic competition means for pricing and access.
A clinician-level guide to tadalafil pharmacogenomics, covering CYP3A4/3A5 polymorphisms, PDE5A variants, nitric-oxide pathway genetics, and how genetic testing can guide dosing of Cialis for erectile dysfunction and BPH.
A clinician-grade review of tadalafil (Cialis) pharmacokinetics covering absorption, distribution, metabolism via CYP3A4, and the 17.5-hour elimination half-life that defines its 36-hour clinical window.
What is established, what is plausible but unproven, and what remains unresolved in the postmarketing safety record for tadalafil (Cialis), including FDA label actions and the drug's absolute nitrate contraindication.
How to store Cialis (tadalafil) correctly, what affects tablet stability, and when expired tadalafil loses potency. FDA data, ICH guidelines, and pharmacokinetic evidence reviewed.
A detailed guide to Aetna (CVS Health) coverage for Cialis (tadalafil), including formulary tier, prior authorization criteria, step therapy requirements, appeal steps, and cost-saving options.
Anthem Elevance Health covers tadalafil with prior authorization and step therapy. Learn formulary tier, PA criteria, appeal steps, and how to lower your cost.
A plain-language guide to BCBS Federated coverage for Cialis, including formulary tiers, prior authorization criteria, step therapy requirements, appeal steps, and cost-saving options.
Find out whether Cigna covers Cialis or generic tadalafil for ED and BPH, what prior-authorization criteria apply, how step therapy works, and how to win an appeal if Cigna denies your claim.
A complete guide to Humana coverage for Cialis (tadalafil): formulary tiers, prior authorization criteria, step therapy rules, appeal steps, and cost-saving alternatives for ED and BPH.
A guide to Medicare Advantage coverage of Cialis (tadalafil) for ED and BPH, including formulary tiers, prior authorization, step therapy, appeals, and cost-saving strategies.
State Medicaid coverage for Cialis (tadalafil) varies widely. Learn which states cover it, prior authorization requirements, step therapy rules, appeal processes, and how to access affordable tadalafil through Medicaid.
A complete guide to UnitedHealthcare coverage for Cialis (tadalafil), including formulary tier, prior authorization criteria, step therapy requirements, appeal steps, and cash-pay alternatives.
Current Cialis and generic tadalafil prices in Nebraska for 2026, including cash-pay, insurance, compounded, and discount options across the state.
A clinical guide to getting Cialis (tadalafil) in Hawaii, covering telehealth prescribing, 503A compounding pharmacies, insurance coverage, prior authorization, and pharmacy options across the islands.
A clinical guide to obtaining Cialis (tadalafil) in Idaho through telehealth, in-person prescribers, and 503A compounding pharmacies, including dosing, labs, insurance, and prior authorization.
A complete guide to getting a Cialis or generic tadalafil prescription in New Hampshire through telehealth, in-person doctors, and licensed 503A compounding pharmacies, with dosing, labs, insurance, and prior-authorization details.
A complete clinical guide to getting a Cialis (tadalafil) prescription in New York, covering telehealth visits, lab requirements, pharmacy options, prior authorization, and dosing for ED and BPH.
Evidence-based guide to safely discontinuing tadalafil (Cialis) for ED or BPH, including tapering considerations, rebound risks, and when to consult your prescriber.
A thorough clinical guide to tadalafil (Cialis) dosing in children under 12, covering FDA-approved indications, pulmonary arterial hypertension dosing, off-label uses, safety data, and monitoring requirements.
Evidence-based guide to monitoring tadalafil use in children under 12, covering off-label indications, weight-based dosing, lab schedules, hemodynamic tracking, and growth surveillance.